Estimating the attributable risk of vascular disorders in different ranges of fasting plasma glucose and assessing the effectiveness of anti-diabetes agents on risk reduction; questioning the current diagnostic criteria
Esmaeil Mohammadi, Farshad Farzadfar(Tehran University of Medical Sciences), Shohreh Naderimagham(Tehran University of Medical Sciences), Negar Rezaei(Tehran University of Medical Sciences), Sina Azadnajafabad(Tehran University of Medical Sciences), Sahar Saeedi Moghaddam(Kiel Institute for the World Economy), Kosar Jamshidi(Iran University of Medical Sciences), Narges Ebrahimi(Tehran University of Medical Sciences), Nima Fattahi(Tehran University of Medical Sciences), Mehrdad Azmin(Tehran University of Medical Sciences), Shahin Roshani(The Netherlands Cancer Institute), Maryam Karimian(Tehran University of Medical Sciences), Bagher Larijani(Tehran University of Medical Sciences), Fatemeh Sadeghi(Isfahan University of Technology), Mahtab Rouhifard(Institute of Cancer Research)
Cited by 14